Showing 1521-1530 of 2157 results for "".
- Dr. Charles Runels Explains Science Behind Popular PRP Procedures for Female Genitaliahttps://modernaesthetics.com/news/dr-charles-runels-explains-science-behind-popular-prp-procedures-for-female-genitalia/2485048/New clinical data presented by Charles Runels, MD, founder of the Cellular Medicine Association (CMA), reveal sustained improvements in female sexual function 1 year after treatment with the O-Shot®, a platelet-rich plasma (PRP) protocol for vaginal and clitoral injection. Dr. Runels share
- Facial Aesthetic Surgical Training May Lag Behind Market Demand, Study Findshttps://modernaesthetics.com/news/facial-aesthetic-surgical-training-may-lag-behind-market-demand-study-finds/2484290/A new analysis published in the Journal of Plastic, Reconstructive & Aesthetic Surgery suggests that US plastic surgery residency programs may not be fully aligned with procedural trends in the growing facial aesthetics market. The study compares Accreditation Council for Graduate Me
- New Serum Targets Menopausal Skin Changes with Plant-Based Technologyhttps://modernaesthetics.com/news/new-serum-targets-menopausal-skin-changes-with-plant-based-technology/2483594/In recognition of Menopause Awareness Month, skinbetter science® announced the release of Mystro Revive Renewing Serum, a new topical product aimed at addressing visible skin changes associated with perimenopause and menopause.
- Study Evaluates Ready-To-Use Botox for Lateral Canthal, Glabellar Lines Treatmenthttps://modernaesthetics.com/news/study-evaluates-ready-to-use-botox-for-lateral-canthal-glabellar-lines-treatment/2483549/Newly published research in Dermatologic Surgery found liquid nivobotulinumtoxinA was effective and well-tolerated in treating moderate-to-severe lateral canthal lines (LCLs) and glabellar lines (GLs). Jean Carruthers, MD, FRCSC, FRC, co-authored the study, titled “NivobotulinumtoxinA in
- Revance Brings Mepivacaine-Based Fillers to US Markethttps://modernaesthetics.com/news/revance-brings-mepivacaine-based-fillers-to-us-market/2483155/Revance has announced the US launch of the Teoxane RHA® Collection with Mepivacaine, marking a significant innovation in dermal filler formulations. The update reflects a shift in anesthetic agents used in hyaluronic acid fillers, with mepivacaine replacing lidocaine as the primary ane
- Study: Rohrer Aesthetics Positions PIX:E as Breakthrough in Preventative Aesthetic Medicinehttps://modernaesthetics.com/news/study-rohrer-aesthetics-positions-pixe-as-breakthrough-in-preventative-aesthetic-medicine/2475544/Rohrer Aesthetics has released new clinical findings on its latest treatment platform, PIX:E, in a study recently featured by NewBeauty. The results suggest that PIX:E may offer a new paradigm in aesthetic care—shifting the focus from reactive treatment to preventative skin health. <
- Cartessa Aesthetics Brings Aesthetic Devices to Canadahttps://modernaesthetics.com/news/cartessa-aesthetics-brings-aesthetic-devices-to-canada/2475372/Cartessa Aesthetics is expanding its Canadian portfolio with the launch of four new technologies, HELIX, TORO, EVERESSE, and ULTRAFORMER MPT, according to a press release from the manufacturer. The new devices are expected to give Canadian providers access to some of the most ad
- Research Letter: Molecule Enhances Skin Barrier, Reduces Retinoid Side Effectshttps://modernaesthetics.com/news/research-letter-molecule-enhances-skin-barrier-reduces-retinoid-side-effects/2473752/A formulation containing Epicutis Skincare’s proprietary TSC molecule significantly reduced erythema and dryness caused by tretinoin, according to a research letter published in the Journal of Cosmetic Dermatology. The
- Allergan Aesthetics Unveiling New AA Signature Program, Immersive Booth at IMCAS World Congress 2025https://modernaesthetics.com/news/allergan-aesthetics-unveiling-new-aa-signature-program-immersive-booth-at-imcas-world-congress-2025/2473731/Allergan Aesthetics, an AbbVie company, is elevating the patient journey with the launch of its news AA Signature Program at the International Master Course of Aging Science (IMCAS) World Congress 2025 in Paris from January 31 through February 1. The new AA Signature Program will provide
- Allergen Aesthetics Brings Back JUVÉDERM® Dayhttps://modernaesthetics.com/news/allergen-aesthetics-brings-back-juvederm-day/2473639/Allergan Aesthetics announced the return of JUVÉDERM® Day on Wednesday, August 21. The event, held for the first time last year, features limited-time offers, savings, and exclusive deals through Allē, the Allergan Aesthetics loyalty rewards program.